Member Policies - Medical Policies - Alabama
Policies & Guidelines
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing Management
- Hemophilia Drug Management
- Medical Policies
- PET, MRI, MRA, CT, CTA/CCTA
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy Management (RTM)
- Self-Administered Drug Policies
- Transgender Services
Draft Medical Policies
Participating providers are invited to submit for consideration scientific, evidence-based information, professional consensus opinions, and other information supported by medical literature relevant to our draft policies.
We accept comments for 45 days from the posting date listed on the draft policy. Make sure your voice is heard by providing feedback directly to us.
How to Submit Comments on Draft Medical Policies
Complete our medical policy feedback form online or send comments and supporting documentation to us by mail or fax:
Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001
Fax: 205-220-0878
Current Draft Policies
| Policy # | Policy Title | Print View |
|---|---|---|
| MP-527 | Bio-Engineered Skin and Soft Tissue Substitutes |
Node: bclrgrpappp1001.corp.bcbsal.org:8080